CCCC
C4 Therapeutics, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website c4therapeutics.com
- Employees(FY) 146
- ISIN US12529R1077
Performance
-16.47%
1W
-16.84%
1M
-28.82%
3M
+212.09%
6M
+0.53%
YTD
+80.89%
1Y
Profile
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting IKZF1 and IKZF3 for multiple myeloma and non-Hodgkin lymphomas, including peripheral T-cell lymphoma and mantle cell lymphoma. The company is also developing CFT8634, an orally bioavailable BiDAC degrader of BRD9, a protein target for synovial sarcoma and SMARCB1-deleted solid tumors; CFT1946, an orally bioavailable BiDAC degrader targeting V600X mutant BRAF to treat melanoma, non-small cell lung cancer (NSCLC), colorectal cancer, and other solid malignancies; CFT8919, an orally bioavailable, allosteric, and mutant-selective BiDAC degrader of epidermal growth factor receptor, or EGFR, with an L858R mutation in NSCLC; and earlier stage programs comprising RET degraders for the treatment of various cancers. C4 Therapeutics, Inc. has strategic collaborations with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; Biogen MA, Inc.; and Calico Life Sciences LLC. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
Technical Analysis of CCCC 2024-05-10
Overview:
In analyzing the technical indicators for CCCC stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions to guide in...
Recent News & Updates
- 2024-05-10 02:52
- 2024-05-09 10:52
- 2024-05-08 07:00
- 2024-05-08 02:53
- 2024-05-08 01:54
- 2024-05-07 19:00
- 2024-04-29 16:01
- 2024-04-29 04:01
- 2024-04-09 07:00
- 2024-04-08 19:00
- 2024-04-08 08:00
- 2024-04-07 20:00
- 2024-03-28 04:36
- 2024-03-27 16:36
- 2024-03-05 16:30
- 2024-03-05 03:30
- 2024-03-04 07:00
- 2024-03-03 18:00
- 2024-02-27 05:29
- 2024-02-24 07:38
C4 Therapeutics Full Year 2023 Earnings: Misses Expectations(Simply Wall St.)
- 2024-02-22 08:15
- 2024-02-22 07:36
- 2024-02-22 07:00
- 2024-02-21 19:15
- 2024-02-21 18:00
- 2024-02-20 10:00
- 2024-02-15 10:19
- 2024-02-15 10:00
- 2024-02-14 21:19
- 2024-02-14 21:00
Page 1 of 5
previousnext